Literature DB >> 23698127

Predictive value of 1 month retinal nerve fiber layer thinning for deficits at 6 months after acute optic neuritis.

Mark J Kupersmith1, Susan Anderson, Randy Kardon.   

Abstract

BACKGROUND: Retinal nerve fiber layer (RNFL) loss occurs with multiple sclerosis and after optic neuritis. Vision or RNFL changes at presentation of optic neuritis are not predictive of outcome, but vision loss at 1 month correlates with vision deficits at 6 months. We hypothesized that RFNL thinning at 1 month would predict RNFL loss at 6 months.
METHODS: We prospectively studied the RNFL by optical coherence tomography (OCT) and scanning laser polarimetry (SLP), and determined the threshold field mean deviation, in 25 subjects with acute optic neuritis over a 6-month period. RNFL values, including the amount of thinning at 1-month, were correlated with 6-month outcome.
RESULTS: Baseline visual performance and RNFL values were similar for eyes grouped by 1 month RNFL thinning. Eyes with 1 month RNFL thinning had greater and significant RNFL thinning at 6 months, for all quadrants by OCT and for the nasal and inferior quadrants by SLP. RNFL thinning by OCT and SLP at 1 month correlated with 6-month OCT (r = 0.58; p = 0.006) and SLP (r = 0.59; p = 0.002) RNFL thinning, respectively.
CONCLUSION: Early RNFL loss at 1 month was predictive of the RNFL thinning at 6 months, which corroborated the importance of the 1-month time point for predicting the outcome of an optic neuritis attack.

Entities:  

Keywords:  Outcome measurement; axonal loss; nerve thinning; optic neuritis; outcome prediction; retinal nerve fiber layer; visual impairment

Mesh:

Year:  2013        PMID: 23698127     DOI: 10.1177/1352458513485149

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  7 in total

1.  Retinal ganglion cell layer thinning within one month of presentation for optic neuritis.

Authors:  Mark J Kupersmith; Mona K Garvin; Jui-Kai Wang; Mary Durbin; Randy Kardon
Journal:  Mult Scler       Date:  2015-09-11       Impact factor: 6.312

2.  Acute Management of Optic Neuritis: An Evolving Paradigm.

Authors:  Lindsay Horton; Jeffrey L Bennett
Journal:  J Neuroophthalmol       Date:  2018-09       Impact factor: 3.042

Review 3.  Early Aggressive Treatment Approaches for Multiple Sclerosis.

Authors:  Alexandra Simpson; Ellen M Mowry; Scott D Newsome
Journal:  Curr Treat Options Neurol       Date:  2021-05-15       Impact factor: 3.598

4.  Does time equal vision in the acute treatment of a cohort of AQP4 and MOG optic neuritis?

Authors:  Hadas Stiebel-Kalish; Mark Andrew Hellmann; Michael Mimouni; Friedemann Paul; Omer Bialer; Michael Bach; Itay Lotan
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2019-05-21

5.  Fingolimod after a first unilateral episode of acute optic neuritis (MOVING) - preliminary results from a randomized, rater-blind, active-controlled, phase 2 trial.

Authors:  Christian Albert; Janine Mikolajczak; Anja Liekfeld; Sophie K Piper; Michael Scheel; Hanna G Zimmermann; Claus Nowak; Jan Dörr; Judith Bellmann-Strobl; Claudia Chien; Alexander U Brandt; Friedemann Paul; Olaf Hoffmann
Journal:  BMC Neurol       Date:  2020-03-03       Impact factor: 2.474

6.  Optimal Intereye Difference Thresholds in Retinal Nerve Fiber Layer Thickness for Predicting a Unilateral Optic Nerve Lesion in Multiple Sclerosis.

Authors:  Rachel C Nolan; Steven L Galetta; Teresa C Frohman; Elliot M Frohman; Peter A Calabresi; Carmen Castrillo-Viguera; Diego Cadavid; Laura J Balcer
Journal:  J Neuroophthalmol       Date:  2018-12       Impact factor: 3.042

7.  Bilateral retinal pathology following a first-ever clinical episode of autoimmune optic neuritis.

Authors:  Carla A Wicki; Praveena Manogaran; Tanja Simic; James V M Hanson; Sven Schippling
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2020-01-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.